Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.
about
RHYTHM-AF: design of an international registry on cardioversion of atrial fibrillation and characteristics of participating centers.Baseline NT-ProBNP level predicts success of cardioversion of atrial fibrillation with flecainideC reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion.Treatment of supraventricular tachycardia in infants: Analysis of a large multicenter database.Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation.Rhythm control and cardioversionSafety and efficacy of vernakalant for the conversion of atrial fibrillation to sinus rhythm; a phase 3b randomized controlled trialCurrent treatment options for atrial flutter and results with cryocatheter ablation.Cardioversion for atrial fibrillation: treatment options and advances.Current concepts in ablation of atrial fibrillation.The efficacy and tolerability of commonly used agents to prevent recurrence of atrial fibrillation after successful cardioversion.Adjunctive Pharmacotherapy for Elective Direct Current Cardioversion in Patients With Atrial Fibrillation.Pharmacologic reversion of persistent atrial fibrillation with amiodarone predicts long-term sinus rhythm maintenance.Efficacy and safety of intravenous vernakalant for the rapid conversion of recent-onset atrial fibrillation: A meta-analysis.Management of Atrial Fibrillation.
P2860
Q34432030-43A60B98-0CFA-4738-8289-D207D6E1C4F0Q35155110-A7B387CB-F345-4CC7-B716-57E6463E002CQ35584790-B4743741-C0DE-452F-A148-132AE92F581CQ35613224-E12DF53B-0333-43B6-A29A-07B9E7D1BEF0Q35771784-78E6B397-B9F6-40A9-81FA-66C6D179F9AAQ35772996-4743CD91-A4B3-410E-9B70-310285EA2483Q36032636-7F071A37-46C1-406F-858C-2B96EB8A22C0Q36410429-276A7AF3-DD79-4846-998C-7FF9C08DE5E8Q37573899-AE341856-921A-4959-B8C6-6AEDC0AA5E54Q37643060-19E5894E-C613-4096-B5D9-BCDE31CAAAECQ38194112-829F7DB9-D61B-4F90-89C8-3ED63A4D81E7Q38872395-F0D66123-F863-403D-A728-5508F1D13F9FQ44594360-1B8B5E19-6DE5-485F-8610-90EF4C5B8ABBQ48362682-EA667D7F-D0C9-4EAE-8BAA-C0387272246AQ51735257-FE56F4D9-6679-40CA-9F99-3B6BCFD1339A
P2860
Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation.
description
1999 nî lūn-bûn
@nan
1999 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Pharmacologic versus direct-cu ...... rial flutter and fibrillation.
@ast
Pharmacologic versus direct-cu ...... rial flutter and fibrillation.
@en
type
label
Pharmacologic versus direct-cu ...... rial flutter and fibrillation.
@ast
Pharmacologic versus direct-cu ...... rial flutter and fibrillation.
@en
prefLabel
Pharmacologic versus direct-cu ...... rial flutter and fibrillation.
@ast
Pharmacologic versus direct-cu ...... rial flutter and fibrillation.
@en
P2093
P1476
Pharmacologic versus direct-cu ...... rial flutter and fibrillation.
@en
P2093
Schoonderwoerd BS
Tieleman RG
Tuinenburg AE
Van Gelder IC
P304
P356
10.1016/S0002-9149(99)00715-8
P407
P577
1999-11-01T00:00:00Z